https://arxiv.org/api/EybDMKnFZ5A+fKdGJ/ltsIQkd5o2026-06-18T10:08:50Z159625515http://arxiv.org/abs/2502.18864v1Towards an AI co-scientist2025-02-26T06:17:13ZScientific discovery relies on scientists generating novel hypotheses that undergo rigorous experimental validation. To augment this process, we introduce an AI co-scientist, a multi-agent system built on Gemini 2.0. The AI co-scientist is intended to help uncover new, original knowledge and to formulate demonstrably novel research hypotheses and proposals, building upon prior evidence and aligned to scientist-provided research objectives and guidance. The system's design incorporates a generate, debate, and evolve approach to hypothesis generation, inspired by the scientific method and accelerated by scaling test-time compute. Key contributions include: (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling; (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute, improving hypothesis quality. While general purpose, we focus development and validation in three biomedical areas: drug repurposing, novel target discovery, and explaining mechanisms of bacterial evolution and anti-microbial resistance. For drug repurposing, the system proposes candidates with promising validation findings, including candidates for acute myeloid leukemia that show tumor inhibition in vitro at clinically applicable concentrations. For novel target discovery, the AI co-scientist proposed new epigenetic targets for liver fibrosis, validated by anti-fibrotic activity and liver cell regeneration in human hepatic organoids. Finally, the AI co-scientist recapitulated unpublished experimental results via a parallel in silico discovery of a novel gene transfer mechanism in bacterial evolution. These results, detailed in separate, co-timed reports, demonstrate the potential to augment biomedical and scientific discovery and usher an era of AI empowered scientists.2025-02-26T06:17:13Z81 pages in total (main 38 pages, appendix 43 pages), 13 main figures, 40 appendix figures, 1 main table, 2 appendix tables, 143 main references, 7 appendix referencesJuraj GottweisWei-Hung WengAlexander DaryinTao TuAnil PalepuPetar SirkovicArtiom MyaskovskyFelix WeissenbergerKeran RongRyutaro TannoKhaled SaabDan PopoviciJacob BlumFan ZhangKatherine ChouAvinatan HassidimBurak GokturkAmin VahdatPushmeet KohliYossi MatiasAndrew CarrollKavita KulkarniNenad TomasevYuan GuanVikram DhillonEeshit Dhaval VaishnavByron LeeTiago R D CostaJosé R PenadésGary PeltzYunhan XuAnnalisa PawloskyAlan KarthikesalingamVivek Natarajanhttp://arxiv.org/abs/2502.18537v1Co-Translational mRNA Decay in Plants: Recent advances and future directions2025-02-25T06:14:08ZTight regulation of messenger RNA (mRNA) stability is essential to ensure accurate gene expression in response to developmental and environmental cues. mRNA stability is controlled by mRNA decay pathways, which have traditionally been proposed to occur independently of translation. However, the recent discovery of a co-translational mRNA decay pathway (also known as CTRD) reveals that mRNA translation and decay can be coupled. While being translated, a mRNA can be targeted for degradation. This pathway was first described in yeast and rapidly identified in several plant species. This review explores recent advances in our understanding of CTRD in plants, emphasizing its regulation and its importance for development and stress response. The different metrics used to assess CTRD activity are also presented. Furthermore, this review outlines future directions to explore the importance of mRNA decay in maintaining mRNA homeostasis in plants.2025-02-25T06:14:08ZJean-Marc DeragonRémy Merrethttp://arxiv.org/abs/2502.15597v1From FAIR to CURE: Guidelines for Computational Models of Biological Systems2025-02-21T17:16:18ZGuidelines for managing scientific data have been established under the FAIR principles requiring that data be Findable, Accessible, Interoperable, and Reusable. In many scientific disciplines, especially computational biology, both data and models are key to progress. For this reason, and recognizing that such models are a very special type of 'data', we argue that computational models, especially mechanistic models prevalent in medicine, physiology and systems biology, deserve a complementary set of guidelines. We propose the CURE principles, emphasizing that models should be Credible, Understandable, Reproducible, and Extensible. We delve into each principle, discussing verification, validation, and uncertainty quantification for model credibility; the clarity of model descriptions and annotations for understandability; adherence to standards and open science practices for reproducibility; and the use of open standards and modular code for extensibility and reuse. We outline recommended and baseline requirements for each aspect of CURE, aiming to enhance the impact and trustworthiness of computational models, particularly in biomedical applications where credibility is paramount. Our perspective underscores the need for a more disciplined approach to modeling, aligning with emerging trends such as Digital Twins and emphasizing the importance of data and modeling standards for interoperability and reuse. Finally, we emphasize that given the non-trivial effort required to implement the guidelines, the community moves to automate as many of the guidelines as possible.2025-02-21T17:16:18ZHerbert M. SauroEran AgmonMichael L. BlinovJohn H. GennariJoe HellersteinAdel HeydarabadipourPeter HunterBartholomew E. JardineElebeoba MayDavid P. NickersonLucian P. SmithGary D BaderFrank BergmannPatrick M. BoyleAndreas DragerJames R. FaederSong FengJuliana FreireFabian FrohlichJames A. GlazierThomas E. GorochowskiTomas HelikarStefan HoopsPrincess ImoukhuedeSarah M. KeatingMatthias KonigReinhard LaubenbacherLeslie M. LoewCarlos F. LopezWilliam W. LyttonAndrew McCullochPedro MendesChris J. MyersJerry G. MyersLealem MulugetaAnna NiarakisDavid D. van NiekerkBrett G. OlivierAlexander A. PatrieEllen M. QuardokusNicole RaddeJohann M. RohwerSven SahleJames C. SchaffT. J. SegoJanis ShinJacky L. SnoepRajanikanth VadigepalliH. Steve WileyDagmar WaltemathIon Moraruhttp://arxiv.org/abs/2502.15867v1Strategic priorities for transformative progress in advancing biology with proteomics and artificial intelligence2025-02-21T13:20:33ZArtificial intelligence (AI) is transforming scientific research, including proteomics. Advances in mass spectrometry (MS)-based proteomics data quality, diversity, and scale, combined with groundbreaking AI techniques, are unlocking new challenges and opportunities in biological discovery. Here, we highlight key areas where AI is driving innovation, from data analysis to new biological insights. These include developing an AI-friendly ecosystem for proteomics data generation, sharing, and analysis; improving peptide and protein identification and quantification; characterizing protein-protein interactions and protein complexes; advancing spatial and perturbation proteomics; integrating multi-omics data; and ultimately enabling AI-empowered virtual cells.2025-02-21T13:20:33Z28 pages, 2 figures, perspective in AI proteomicsYingying SunJun AZhiwei LiuRui SunLiujia QianSamuel H. PayneWout BittremieuxMarkus RalserChen LiYi ChenZhen DongYasset Perez-RiverolAsif KhanChris SanderRuedi AebersoldJuan Antonio VizcaínoJonathan R KriegerJianhua YaoHan WenLinfeng ZhangYunping ZhuYue XuanBenjamin Boyang SunLiang QiaoHenning HermjakobHaixu TangHuanhuan GaoYamin DengQing ZhongCheng ChangNuno BandeiraMing LiWeinan ESiqi SunYuedong YangGilbert S. OmennYue ZhangPing XuYan FuXiaowen LiuChristopher M. OverallYu WangEric W. DeutschLuonan ChenJürgen CoxVadim DemichevFuchu HeJiaxing HuangHuilin JinChao LiuNan LiZhongzhi LuanJiangning SongKaicheng YuWanggen WanTai WangKang ZhangLe ZhangPeter A. BellMatthias MannBing ZhangTiannan Guohttp://arxiv.org/abs/2502.14929v1Cytogenetic, Hematobiochemical, and Histopathological Assessment of Albino Rats (Rattus norvegicus) Fed on Gluten Extracts2025-02-20T05:44:36ZBackground: Literature shows that most of the information on the toxicity of gluten is generated from survey and observational studies, resulting in inconsistent outcomes and a decrease in the acceptability of gluten-rich foods. To determine gluten's safety, an in-depth in vitro and in vivo toxicological examination is required. This enables scientists to come up with ameliorative strategies if it turns out to have side effects, and consumers' trust can be restored. Objectives: The objective of this study was to assess the toxicity of gluten extracts on albino rats (Rattus norvegicus). Materials and Methods: Twenty-four rats were randomly selected and divided into four groups, each comprising six rats. Group 1 (control) rats were fed on pellet feeds and groups 2, 3, and 4 were fed on daily dosages of 0.5, 1.0, and 1.5 g gluten extracts, respectively. The rats' body weights and reactions were observed for 90 days before blood samples were collected for hematobiochemical and micronucleus tests. Histopathological examinations of the liver and kidneys were also performed. Results: There was no difference (P > 0.05) in body weight, blood glucose level, or micronuclei between the control and treated rats. The lymphocytes, alkaline phosphatase, alanine transaminase, total protein, and calcium ions of the test rats were all significantly (P < 0.05) altered but remained within the normal ranges. Other hematobiochemical parameters, including packed cell volume, hemoglobin, white and red blood cells, aspartate transaminase, albumin, sodium ions, potassium ions, chloride ions, and urea, revealed no marked changes. The treated rats' livers and kidneys showed no histopathological changes. Conclusion: Gluten had no adverse effects. However, it altered hematobiochemical parameters, particularly the lymphocytes, alkaline phosphatase, alanine transaminase, total protein, and calcium ions.2025-02-20T05:44:36Z11 pagesTajudeen YahayaEsther OladeleUfuoma ShemishereDaniel AnyebeHaliru AbdullahiMaryam LawalRufai Ahmadhttp://arxiv.org/abs/2503.07613v1HIV/AIDS Suppression in North America: Intervention Plans and Cost-Effectiveness of UNAIDS 90-90-90 and 95-95-95 Targets2025-02-19T04:03:18ZThis study utilizes mathematical models to assess progress toward achieving the UNAIDS 90-90-90 and 95-95-95 targets aimed at managing and eradicating HIV/AIDS. It contrasts stochastic and deterministic models, focusing on their utility in optimizing public health strategies. Stochastic models account for real-world unpredictability, offering more realistic insights compared to deterministic approaches. The 95-95-95 targets aim for 95\% of people living with HIV to know their status, 95\% of those diagnosed to receive antiretroviral therapy (ART), and 95\% of those on ART to achieve viral suppression. These benchmarks are critical for reducing transmission and improving health outcomes. This analysis establishes the basic reproduction number ($R_0$) to guide interventions and examines the stability of disease-free and endemic equilibria, providing a foundation for applying optimal control strategies to minimize HIV prevalence effectively and cost-efficiently. Moreover, the data for this study was sourced from the official UNAIDS website, focusing on North America. An innovative feature of this study is the application of the Stochastic method, which enhances model accuracy and operational efficiency in simulating HIV transmission under various interventions. This research offers actionable insights for policymakers and contributes to global efforts to achieve the 95-95-95 targets by 2030, advancing the fight against HIV/AIDS.2025-02-19T04:03:18Z41 pagesNuzhat Nuari Khan RivuMd KamrujjamanAsif Iqbalhttp://arxiv.org/abs/2408.01242v3Dareplane: A modular open-source software platform for BCI research with application in closed-loop deep brain stimulation2025-02-17T23:59:58ZObjective - This work introduces Dareplane, a modular and broad technology-agnostic open source software platform for brain-computer interface research with an application focus on adaptive deep brain stimulation (aDBS). One difficulty for investigating control approaches for aDBS resides with the complex setups required for aDBS experiments, a challenge Dareplane tries to address. Approach - The key features of the platform are presented and the composition of modules into a full experimental setup is discussed in the context of a Python-based orchestration module. The performance of a typical experimental setup on Dareplane for aDBS is evaluated in three benchtop experiments, covering (a) an easy-to-replicate setup using an Arduino microcontroller, (b) a setup with hardware of an implantable pulse generator, and (c) a setup using an established and CE certified external neurostimulator. The full technical feasibility of the platform in the aDBS context is demonstrated in a first closed-loop session with externalized leads on a patient with Parkinson's disease receiving DBS treatment and further in a non-invasive BCI speller application using code-modulated visual evoked responses (c-VEP). Main results - The platform is implemented and open-source accessible on https://github.com/bsdlab/Dareplane. Benchtop results show that performance of the platform is sufficient for current aDBS latencies, and the platform could successfully be used in the aDBS experiment. The timing-critical c-VEP speller could be successfully implemented on the platform achieving expected information transfer rates. Significance - The Dareplane platform supports aDBS setups, and more generally the research on neurotechnological systems such as brain-computer interfaces. It provides a modular, technology-agnostic, and easy-to-implement software platform to make experimental setups more resilient and replicable.2024-08-02T13:01:02ZMatthias DoldJoana PereiraBastian SajonzVolker A. CoenenJordy ThielenMarcus L. F. JanssenMichael Tangermannhttp://arxiv.org/abs/2502.09351v1Data Sharing in the PRIMED Consortium: Design, implementation, and recommendations for future policymaking2025-02-12T17:31:39ZSharing diverse genomic and other biomedical datasets is critical to advance scientific discoveries and their equitable translation to improve human health. However, data sharing remains challenging in the context of legacy datasets, evolving policies, multi-institutional consortium science, and international stakeholders. The NIH-funded Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium was established to improve the performance of polygenic risk estimates for a broad range of health and disease outcomes with global impacts. Improving polygenic risk score performance across genetically diverse populations requires access to large, diverse cohorts. We report on the design and implementation of data sharing policies and procedures developed in PRIMED to aggregate and analyze data from multiple, heterogeneous sources while adhering to existing data sharing policies for each integrated dataset. We describe two primary data sharing mechanisms: coordinated dbGaP applications and a Consortium Data Sharing Agreement, as well as provide alternatives when individual-level data cannot be shared within the Consortium (e.g., federated analyses). We also describe technical implementation of Consortium data sharing in the NHGRI Analysis Visualization and Informatics Lab-space (AnVIL) cloud platform, to share derived individual-level data, genomic summary results, and methods workflows with appropriate permissions. As a Consortium making secondary use of pre-existing data sources, we also discuss challenges and propose solutions for release of individual- and summary-level data products to the broader scientific community. We make recommendations for ongoing and future policymaking with the goal of informing future consortia and other research activities.2025-02-12T17:31:39ZJohanna L. SmithQuenna WongWhitney HornsbyMatthew P. ConomosBenjamin D. HeavnerIftikhar J. KulloBruce M. PsatyStephen S. RichBamidele TayoPradeep NatarajanSarah C. NelsonPolygenic Risk Methods in Diverse Populations PRIMED Consortium Data Sharing Working GroupPolygenic Risk Methods in Diverse Populations PRIMED Consortiumhttp://arxiv.org/abs/2502.08264v1Research on Cumin Peptides Using PBS Extraction and Their Multifunctional Bioactivities2025-02-12T10:16:16ZThis study employed neutral PBS buffer combined with ammonium sulfate fractionation to isolate peptide-active fractions (PD-30, PD-50, PD-80) from Cuminum cyminum L.seeds (cumin) and systematically evaluated their antimicrobial, antioxidant, hypoglycemic, and anticancer activities. The results demonstrated that the PD-80 fraction exhibited potent antifungal activity against Candida albicans (inhibition zone diameter: 12.5 mm) and significant antioxidant capacity, with DPPH and ABTS radical scavenging rates of 72.4% and 78.9%. The PD-50 fraction showed the strongest antibacterial effect against Escherichia coli (inhibition zone diameter: 11.7mm), while PD-30 displayed the highest inhibitory activity against PTP1B (IC50=18.39 ug/mL), indicating its potential for hypoglycemic applications. Through mass spectrometry and database alignment, 414 peptides were identified for the first time in cumin-derived PBS extracts, including 18 structurally novel monomers comprising 11 antimicrobial peptides, 7 anticancer peptides, and 6 hypoglycemic peptides. Notably, peptide CK12 shares sequence homology (59% similarity) with the HIV fusion inhibitor T20, suggesting potential antiviral activity. This study elucidates the multifunctionality and structural basis of cumin peptides, providing a theoretical foundation for their application in natural pharmaceuticals and functional foods. Future research will focus on chemical modification and in vivo validation to advance their utilization in precision medicine and the modernization of traditional Chinese medicine.2025-02-12T10:16:16ZThis research article including 18 pages, along with 6 figures, 5 tables and 42 referencesYasen Mijiti YangjianSumairemu SubuerNajeeb UllahErmatov IsmoilHailiqian TaoerdahongPaerhati Rouzihttp://arxiv.org/abs/2408.09344v2GitHub is an effective platform for collaborative and reproducible laboratory research2025-02-10T22:42:25ZLaboratory research is a complex, collaborative process that involves several stages, including hypothesis formulation, experimental design, data generation and analysis, and manuscript writing. Although reproducibility and data sharing are increasingly prioritized at the publication stage, integrating these principles at earlier stages of laboratory research has been hampered by the lack of broadly applicable solutions. Here, we propose that the workflow used in modern software development offers a robust framework for enhancing reproducibility and collaboration in laboratory research. In particular, we show that GitHub, a platform widely used for collaborative software projects, can be effectively adapted to organize and document all aspects of a research project's lifecycle in a molecular biology laboratory. We outline a three-step approach for incorporating the GitHub ecosystem into laboratory research workflows: 1. designing and organizing experiments using issues and project boards, 2. documenting experiments and data analyses with a version control system, and 3. ensuring reproducible software environments for data analyses and writing tasks with containerized packages. The versatility, scalability, and affordability of this approach make it suitable for various scenarios, ranging from small research groups to large, cross-institutional collaborations. Adopting this framework from a project's outset can increase the efficiency and fidelity of knowledge transfer within and across research laboratories. An example GitHub repository based on this approach is available at https://github.com/rasilab/github_demo and a template repository that can be copied is available at https://github.com/rasilab/github_template.2024-08-18T03:35:26Z13 pages, 6 figuresKatharine Y. ChenMaria Toro-MorenoArvind Rasi Subramaniamhttp://arxiv.org/abs/2411.10511v4How quantum computing can enhance biomarker discovery2025-02-09T08:39:16ZBiomarkers play a central role in medicine's gradual progress towards proactive, personalized precision diagnostics and interventions. However, finding biomarkers that provide very early indicators of a change in health status, for example for multi-factorial diseases, has been challenging. Discovery of such biomarkers stands to benefit significantly from advanced information processing and means to detect complex correlations, which quantum computing offers. In this perspective paper, quantum algorithms, particularly in machine learning, are mapped to key applications in biomarker discovery. The opportunities and challenges associated with the algorithms and applications are discussed. The analysis is structured according to different data types - multi-dimensional, time series, and erroneous data - and covers key data modalities in healthcare - electronic health records (EHRs), omics, and medical images. An outlook is provided concerning open research challenges.2024-11-15T16:50:05ZHow quantum computing can enhance biomarker discovery. Patterns (2025)Frederik F. FlötherDaniel BlankenbergMaria DemidikKarl JansenRaga KrishnakumarRajiv KrishnakumarNouamane LaanaitLaxmi ParidaCarl SaabFilippo Utro10.1016/j.patter.2025.101236http://arxiv.org/abs/2502.03269v1Modeling and Optimization of Insulin Injection for Type-1 Diabetes Mellitus Management2025-02-05T15:24:46ZDiabetes mellitus is a global health crisis characterized by poor blood sugar regulation, impacting millions of people worldwide and leading to severe complications and mortality. Although Type 1 Diabetes Mellitus (T1DM) has a lower number of cases compared to other forms of diabetes, it is often diagnosed at a young age and requires lifelong exogenous insulin administration. In this paper, we focus on understanding the interaction of insulin and glucose molecules within the subcutaneous layer, which is crucial for blood sugar control in T1DM patients. Specifically, we propose a comprehensive model to characterize the insulin-glucose system within the subcutaneous layer, incorporating a multicellular molecular communication system. We then divide the T1DM system into insulin and glucose subsystems and derive the end-to-end expression for insulin-glucose interaction in the subcutaneous layer. We further validate the insulin-glucose interaction analysis with an agent-based simulator. As effectively managing postprandial glucose levels is crucial for individuals with T1DM to safeguard their overall health and avert short-term and long-term complications, we also derive the optimal insulin administration time based on the derived glucose response via the Lagrange multiplier and gradient descent ascent method. This allows us to explore the impact of different types of insulin and dietary management on blood sugar levels. Simulation results confirm the correctness of our proposed model and the effectiveness of our optimized effective time window for injecting insulin in individuals with T1DM.2025-02-05T15:24:46Z15 pages, 10 figuresRinrada JadsadaphongphaiboolDadi BiChristian D. LorenzYansha DengRobert Schober10.1109/TMBMC.2025.3559470http://arxiv.org/abs/2502.01716v1Design of Engineered Living Materials for Martian Construction2025-02-03T17:12:25ZAs the next step in extraterrestrial exploration, many engineers and scientists around the country revealed their intense interest to enable multiplanetary human life, including colonizing Mars. This study proposes that architecture on Mars can be realized by a synthetic lichen system, composed of diazotrophic cyanobacteria and filamentous fungi, which produce abundant biominerals and biopolymers to bond Martian regolith into consolidated building blocks. These self-growing building blocks can be assembled into a wide range of structures. Diazotrophic cyanobacteria will 1) fix carbon dioxide and dinitrogen from the atmosphere and convert them into oxygen and organic carbon and nitrogen sources to support filamentous fungi; and 2) give rise to high concentrations of carbonate ions because of photosynthetic activities. Filamentous fungi will 1) bind metal ions onto fungal cell walls and serve as nucleation sites to promote biomineral precipitates; and 2) assist the survival and growth of cyanobacteria by providing them water, minerals, additional carbon dioxide, and protection. This report presents the major progress of the project. It has been tested and confirmed that such co-culture systems can be created, and they grow very well solely on Martian regolith simulants, air, light, and an inorganic liquid medium without any additional carbon or nitrogen sources. The cyanobacterial and fungal growth in such co-culture systems is significantly better than their axenic growth due to mutual interactions. The amounts and morphologies of the precipitated crystals vary remarkably depending on the cultivation condition.2025-02-03T17:12:25ZarXiv admin note: text overlap with arXiv:2406.02522Nisha RokayaErin C. CarrRichard A. WilsonCongrui Jinhttp://arxiv.org/abs/2502.00696v1Comprehensive Analysis of Bioactive Peptides from Cuminum cyminum L. Seeds: Sequence Identification and Pharmacological Evaluation2025-02-02T07:09:07ZCuminum cyminum L. (cumin) is a medicinal and edible plant widely used in traditional Chinese medicine (TCM) for treating various ailments, including diarrhea, abdominal pain, inflammation, asthma, and diabetes. While previous research has primarily focused on its essential oils, studies on its protein-derived bioactive peptides remain limited. In this study, we employed an innovative extraction method to isolate peptides from cumin seeds for the first time and screened their biological activities, revealing significant antimicrobial, antioxidant, and hypoglycemic properties. Guided by bioactivity, we utilized advanced separation and structural identification techniques, including Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF/TOF MS/MS), to systematically purify and characterize cumin-derived peptides. A total of 479 unique peptide sequences were identified using Mascot software and the SwissProt/UniProt_Bos databases. Among these, 15 highly bioactive peptides were selected for further analysis based on bioactivity and toxicity predictions using PeptideRanker and ToxinPred. Structural characterization revealed key features, such as α-helices and \b{eta}-sheets, associated with their multifunctional activities. This study provides the first comprehensive analysis of bioactive peptides from Cuminum cyminum L. seeds, elucidating their potential as antimicrobial, antioxidant, and hypoglycemic agents. These findings not only clarify the pharmacological basis of cumin's traditional uses but also lay a theoretical foundation for the development of novel therapeutic agents from this medicinal plant.2025-02-02T07:09:07ZMy research focuses on the Comprehensive Analysis of Bioactive Peptides from Cuminum cyminum L. Seeds: Sequence Identification and Pharmacological Evaluation, an area with significant implications but currently underexplored.The manuscript includes six figures and six tables to support my findings. I'm fully committed to cooperating with any revision requestsErmatov IsmoilSumairemu subuerRena awutiHaili qian TaurtaihonAhmidin waliYasen Mijitihttp://arxiv.org/abs/2501.18660v1NAR db status Version 2 and miRNAverse: Over Two Years of Manual Meta-Registry Curation and Updates2025-01-30T11:02:05ZPreviously, we reported on a new meta-registry for NAR published databases focusing on high-quality annotations regarding database availability and longevity. With over two years of continued manual curation, here, we report on recent updates and additions. Furthermore, the available annotations as well as the underlying database structure have been unified with the miRNAverse meta-registry. This allows for more in-depth insights as well as easier curation and future developments shared across both meta-registries. NAR db status currently provides annotations for 2,082 databases and miRNAverse for 194 databases. With the oldest annotation revision from June 2022 and the newest from January 2025, NAR db status spans two and a half years of continued manual curation. NAR db status is available at https://nardbstatus.de and miRNAverse at https://mirnaverse.de.2025-01-30T11:02:05Z8 pages, 6 figuresMarcel FriedrichsCassandra Königs